Sibel Aksoy
10.4103/ijo.IJO_418_18
Indian J Ophthalmol
2019 Jan;67(1):145-147.
aflibercept anti-vegf corneal vascularization
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/30574927/
Astrocytoma / surgery Cerebellar Neoplasms / surgery Corneal Neovascularization / drug therapy Neurosurgical Procedures / adverse effects Postoperative Complications Receptors, Vascular Endothelial Growth Factor / administration & dosage Recombinant Fusion Proteins / administration & dosage
Astrocytoma / surgery Cerebellar Neoplasms / surgery Corneal Neovascularization / drug therapy Neurosurgical Procedures / adverse effects Postoperative Complications Receptors, Vascular Endothelial Growth Factor / administration & dosage Recombinant Fusion Proteins / administration & dosage Case Reports Administration, Topical Astrocytoma / diagnosis Cerebellar Neoplasms / diagnosis Child Corneal Neovascularization / diagnosis Corneal Neovascularization / etiology Humans Male Vascular Endothelial Growth Factor A / antagonists & inhibitors Visual Acuity Recombinant Fusion Proteins Vascular Endothelial Growth Factor A aflibercept Receptors, Vascular Endothelial Growth Factor
PMC6324144
30574927
Treatment of corneal neovascularization with topical aflibercept in a case of exposure keratopathy following cerebellar astrocytoma surgery
2019